Stocksigma LogoStocksigma Logo

KRM Ayurveda Reports Strong Q2 and H1 FY27 Results with Significant Margin Expansion

KRM Ayurveda reported robust financial performance for H1 FY27, with total income rising 40.10% YoY to ₹68.17 crore and PAT surging 109.55% YoY to ₹17.23

KRM Ayurveda Reports Strong Q2 and H1 FY27 Results with Significant Margin Expansion

KRM Ayurveda Ltd · Press Release · 14 Nov 2026, 10:53 pm

KRM Ayurveda Reports Strong Q2 and H1 FY27 Results with Significant Margin Expansion KRM Ayurveda reported robust financial performance for H1 FY27, with total income rising 40.10% YoY to ₹68.17 crore and PAT surging 109.55% YoY to ₹17.23 crore. EBITDA grew 79.81% YoY to ₹23.82 crore, expanding EBITDA margins by 772 bps to 34.95%. For Q2 FY27, revenue climbed 48.08% YoY to ₹35.30 crore, while PAT rose 95.37% YoY to ₹8.15 crore. Operationally, the company expanded capacity by adding an 80-bed hospital in Gurugram, entered the nutraceuticals vertical via the 100% acquisition of Karma Nutravedics, and monetized a non-operational asset for ₹3.50 crore.

Original exchange filing (PDF)

More announcements from KRM Ayurveda Ltd

All KRM Ayurveda Ltd announcements